|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2003-9-10
|
|
pubmed:abstractText |
NICE guidance recommends the use of paclitaxel and a platinum therapy for all cases of ovarian cancer. We report our experience of treating 133 patients with ovarian cancer over a 3-year period. Where indicated, 91% received chemotherapy. A taxane/platinum combination was found to be appropriate in 63% of patients only.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0007-0920
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
966-7
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12966409-Adult,
pubmed-meshheading:12966409-Aged,
pubmed-meshheading:12966409-Aged, 80 and over,
pubmed-meshheading:12966409-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12966409-Carboplatin,
pubmed-meshheading:12966409-Combined Modality Therapy,
pubmed-meshheading:12966409-Female,
pubmed-meshheading:12966409-Humans,
pubmed-meshheading:12966409-Middle Aged,
pubmed-meshheading:12966409-Mixed Tumor, Mullerian,
pubmed-meshheading:12966409-Neoplasm Staging,
pubmed-meshheading:12966409-Neoplasms, Glandular and Epithelial,
pubmed-meshheading:12966409-Ovarian Neoplasms,
pubmed-meshheading:12966409-Paclitaxel,
pubmed-meshheading:12966409-Practice Guidelines as Topic,
pubmed-meshheading:12966409-Prospective Studies,
pubmed-meshheading:12966409-Radiotherapy Dosage,
pubmed-meshheading:12966409-Survival Rate,
pubmed-meshheading:12966409-Taxoids
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Is optimal first-line chemotherapy deliverable in all newly diagnosed ovarian cancers? A population-based study.
|
|
pubmed:affiliation |
Department of Gynaecology/Oncology, Ward 43, Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB15 2ZN, Scotland. omcnally@doctors.org.uk
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Comment
|
